Bio Port Korea Inc. (KOSDAQ:188040)

Bio Port Korea Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
Revenue	73,346	68,699
Revenue Growth (YoY)	6.77%	-
Cost of Revenue	52,411	49,616
Gross Profit	20,936	19,083
Selling, General & Admin	14,507	13,179
Research & Development	504.95	457.61
Other Operating Expenses	163.69	133.25
Operating Expenses	15,696	14,164
Operating Income	5,240	4,919
Interest Expense	-1,512	-2,108
Interest & Investment Income	517.44	408.99
Currency Exchange Gain (Loss)	544.78	206.96
Other Non Operating Income (Expenses)	1,467	182.24
EBT Excluding Unusual Items	6,258	3,609
Gain (Loss) on Sale of Investments	18.23	-13.91
Gain (Loss) on Sale of Assets	-924.59	-
Pretax Income	5,352	3,595
Income Tax Expense	1,240	225.62
Net Income	4,112	3,369
Net Income to Common	4,112	3,369
Net Income Growth	22.04%	-
Shares Outstanding (Basic)	3	3
Shares Outstanding (Diluted)	4	4
Shares Change (YoY)	1.04%	-
EPS (Basic)	1465.53	1347.75
EPS (Diluted)	1438.99	1302.58
EPS Growth	10.47%	-
Free Cash Flow	8,491	-1,253
Free Cash Flow Per Share	2372.83	-353.75
Gross Margin	28.54%	27.78%
Operating Margin	7.14%	7.16%
Profit Margin	5.61%	4.91%
Free Cash Flow Margin	11.58%	-1.82%
EBITDA	7,102	6,328
EBITDA Margin	9.68%	9.21%
D&A For EBITDA	1,862	1,409
EBIT	5,240	4,919
EBIT Margin	7.14%	7.16%
Effective Tax Rate	23.16%	6.28%
Advertising Expenses	966.01	768.83

Source: S&P Global Market Intelligence. Standard template. Financial Sources.